Over half a billion people worldwide are living with cardiovascular disease, with about 64 million affected by heart failure (HF). HF is often interconnected with cardiorenal and cardiometabolic diseases, which raises the urgent need to understand its disease drivers. This World Heart Day, explore how early intervention, diagnosis and treatment can transform patient outcomes, in our article published on STAT: https://learn.az/6041oY8Q3 #WorldHeartDay
Great advice!
We’re delighted to win the award for Net Zero: Operations Transformation at the 2024 Reuters Sustainability Awards 🎉 AstraZeneca is recognised for driving deep decarbonisation across our operations and fleet through our over $1 billion Ambition Zero Carbon programme. By taking bold climate action, we aim to reduce Scope 1 and 2 greenhouse gas emissions by 98% by 2026 on the way to becoming net zero by 2045. And we’re making strong progress: by the end of 2023, we had reduced Scope 1 and 2 emissions by 67.6%. One of the ways we‘re doing this is by developing new sustainable sources of energy, including clean and renewable electricity. For example, we’re collaborating with Vanguard Renewables to enable 190 GWh per year or renewable natural gas to be used across our US sites, and in the UK, we’re partnering with Future Biogas to supply 100 GWh per year of biomethane to our UK sites. Find out more about our sustainability impact and how we’re accelerating the delivery of resilient, equitable and net zero healthcare: https://learn.az/6042UV7e8
We are working to advance liver cancer treatments that give patients options for long-term survival and better quality of life. Meet Andrea from Blue Faery: The Adrienne Wilson Liver Cancer Association which aims to raise awareness of clinical trials, treatment options, and assistance programs for patients with liver cancers. Together we aim to one day eliminate GI cancers. #LiverCancerAwarenessMonth
One year can change everything. A 12-month delay in diagnosing stage 3 chronic kidney disease (CKD) raises the risk of needing a kidney transplant or long-term dialysis treatment by 63%. We must act now. At #UNGA79, we— alongside Boehringer Ingelheim and partners the International Society of Nephrology, Global Patient Alliance for Kidney Health, and Devex — brought together global experts to call for CKD to be recognised as an urgent global health priority. Together, we explored how early detection, diagnosis, treatment and care can make a difference. Together, we can make the change. Sign up to learn more: https://learn.az/6045U3gPl #ForKidneyHealth
Digital biomarkers have the potential to help researchers more effectively study rare diseases by providing a better understanding of symptoms and treatment response. Christophe Hotermans, MD PhD, Head of Global Medical Affairs Alexion Pharmaceuticals, Inc. discusses how digital biomarker data can help accelerate the discovery and development of new medicines. Learn more: https://learn.az/6044UOymr #ClinicalInnovation #WhatScienceCanDo
Our Employee resource groups (ERG’s) are designed to support our diverse workforce by promoting a sense of belonging, enabling our employees to share knowledge and help drive positive change on a variety of workplace issues. The Network of Women and Allies is a growing global community designed to support and champion women in the workplace throughout their lives and careers. Learn how one of our workstreams, Menopause & Me, is helping create a supportive environment for colleagues experiencing personal change: https://learn.az/6042Uzh9r #ERG #HealthandWellbeing #LifeatAZ
Our recent publication in Nature Communications reports the function of the enzyme PNPLA3 in balancing lipid levels in the liver and bloodstream. By understanding how loss of function of this enzyme could drive progression of steatotic liver disease, including metabolic dysfunction-associated steatohepatitis (MASH), our scientists are aiming to identify new therapeutic approaches for patients living with this disease. Learn more here: https://learn.az/6049U8RXF
We're playing our part to deliver better healthcare outcomes with a lower environmental footprint. By harnessing the power of sustainable science, and in partnership with ERM, we’re decarbonising our clinical trials and accelerating progress towards net zero healthcare. 🌍 Learn more: https://learn.az/6048WHlyk #WhatScienceCanDo
We joined world leaders in New York for #ClimateWeekNYC and #UNGA79 to discuss climate action and global health priorities. Our EVP for Global Operations & IT, and Chief Sustainability Officer, Pam Cheng, shares her thoughts on the convergence of climate change and the rising burden of non-communicable diseases and health inequities in Foreign Policy: https://learn.az/6041oagX9
Great insights on the growing impact of cardiovascular diseases. Early intervention and comprehensive treatment are indeed crucial in improving patient outcomes